Neuroinfammation induced bylipopolysaccharide causes cognitiveimpairment in mice
1. Neuroinfammation induced by
lipopolysaccharide causes cognitive
impairment in mice
Zhao et al. (2019). Neuroinflammation induced by lipopolysaccharide causes
cognitive impairment in mice. Scientific reports, 9(1), 1-12.
Mohamed Badawy
https://neuroscitoday.com
2. Introduction
• Neuroinflammation plays a major role in neurodegenerative diseases.
i.e AD, PD, MS.
• Microglia is a key factor in neuroinflammation occurrence, and
development.
• Dependent on the duration, and severity, neuroinflammation can be
protective or harmful.
• Prolonged activation of microglia leads to neuronal death, increases the
release of proinflammatory cytokines, and TNF.
• These proinflammatory cytokines were found to be hallmark for many
neurodegenerative diseases.
• LPS, as microglia TLR-4 activator, leads to the release of the pro-
inflammatory cytokines that mimic the chronic activation of microglia.
4. Morris water
navigation task
• Used to assess spatial
learning and memory.
physiologicalresearch.weebly.com/water-maze-test.html
Different insertion points
Opaque water
5. Morris water
navigation task
• Used to assess spatial learning and
memory.
physiologicalresearch.weebly.com/water-maze-test.html
Different insertion points
Opaque water
7. Pole test
• Assesses the motor
coordination.
• evaluates the ability
of a mouse to grasp
and maneuver on a
pole in order to
descend to its home
cage.
• The time taken by mice to
descend the pole is
recorded and scored.
meliordiscovery.com/in-vivo-efficacy-models/pole-test/
Incidentally, the TLR-4-specifc viral inhibitory peptide VIPER has been shown to potentially inhibit TLR-4-mediated responses induced by LPS21. Furthermore, theadministration of LPS to animals induces cognitive impairment22,23 and a complex array of behaviors, includinganorexia, decreased locomotion, weight loss, exploratory behavior, increased anxiety, somnolence, and generalbehavioral depression. Several of these symptoms are thought to be very similar to the clinically relevant symptoms of neurodegenerative disease in humans.
What they do.
Here, we inducedneuroinfammation via intraperitoneal (i.p.) or intracerebroventricular (i.c.v.) injections of LPS and investigatedthe possible mechanisms of LPS-induced cognitive impairment by assessing the interaction between Aβ andneuroinfammation23–25.
Duringthe training trials, the mice were placed into the water in a random quadrant and allowed to locate the hiddenplatform for 60 s. Ten, the mice were allowed to remain on the platform or were placed on the platform for 10 sat the end of each trial. Te mice were trained with three trials per day for 7 days. Afer the training, on the fnalday of testing, we administered LPS or saline 6 h before conducting the spatial probe test. Te escape latency andescape distance displayed by each mouse were recorded by a comp
ll mice were submitted to the “Pole test” to measure their motor coordination. Briefy,the mice were subjected to fve days of training on a pole that was 60 cm in length and 1 cm in diameter withtwo layers of gauze on the outside. On the sixth day, LPS (i.p. 500 μg/kg or 750 μg/kg) was injected 6 h before theclimbing pole test, and the following three times were recorded: the time it took for the mouse to climb downthe upper half, the time it took for the mouse to climb down the lower half, and the time it took for the mouse tocomplete the total length of the pole. If the mouse completed the above three steps within 3 s, 6 s or longer than6 s, the motor coordination score was 3 points, 2 points, or 1 point, respectively.
LPS-induced memory defects in the MWM test and passive avoidance performance test. (A) Miceshowed impaired learning and memory function afer injections of LPS during the place-navigation test. (B)Mice showed an efect of LPS on memory function during the spatial probe test. C: Latency in the passiveavoidance test. D: Error number in the passive avoidance test (n =10). *P< 0.05, **P<0.01 LPS-induced (i.p.500 μg/kg) compared to the i.p. saline group; ΔP< 0.05, ΔΔP< 0.01 LPS-induced (i.p. 750 μg/kg) compared tothe i.p. saline group; #P <0.05, ##P< 0.01, LPS-induced (i.c.v. 12 μg) compared to the i.c.v. saline group.
Figure 3. Motor coordination scores in the LPS-induced mouse model as assessed in mice daily. *P <0.05,**P <0.01 LPS (i.p. 500 μg/kg) compared to the i.p. saline group; ΔP< 0.05, ΔΔP< 0.01 LPS (i.p. 750 μg/kg)compared to the i.p. saline group; #P< 0.05, ##P<0.01, LPS (i.c.v. 12 μg) compared to the i.c.v. saline group.
Figure 4. Expression of MAP-2 and IBA-1 in the LPS-induced mouse model of memory and learningimpairment. Immunostaining of IBA-1 (green) and MAP-2 (red) proteins in the hippocampus was performed withspecifc primary antibodies, quantifed images of n=5 per group. Graph is plotted as the mean+SEM. *P<0.05,**P<0.01 LPS (i.p. 500 μg/kg) compared to the i.p. saline group; ΔP<0.05, ΔΔP<0.01 LPS (i.p. 750 μg/kg)compared to the i.p. saline group; #P<0.05, ##P<0.01, LPS (i.c.v. 12 μg) compared to the i.c.v. saline group.
(A–D) Te expression of the proinfammatory cytokines IL-1β, TNF-α, PGE2 and NOin serum and brain homogenates.
(E) LPS-induced expression of COX-2 and iNOS in the brain; the data weredetermined by Western blotting. Te data are described as the mean ±SEM (n =10). *P< 0.05, **P<0.01 LPS(i.p. 500 μg/kg) compared to the i.p. saline group; ΔP<0.05, ΔΔP< 0.01 LPS (i.p. 750 μg/kg) compared to the i.p.saline group; #P< 0.05, ##P< 0.01, LPS (i.c.v. 12 μg) compared to the i.c.v. saline group.
Te data are described as the mean±SEM (n=10). *P<0.05, **P<0.01 LPS (i.p. 500μg/kg)compared to the i.p. saline group; ΔP<0.05, ΔΔP<0.01 LPS (i.p. 750 μg/kg) compared to the i.p. saline group;#P<0.05, ##P<0.01, LPS (i.c.v. 12 μg) compared to the i.c.v. saline group.
Figure 7. Efects of diferent treatments on NF-κB-related proteins in brain homogenates. Te data aredescribed as the mean ± SEM (n= 10). *P< 0.05, **P<0.01 LPS-induced (i.p.500 μg/kg) compared to the i.p.saline group; ΔP< 0.05, ΔΔP <0.01 LPS-induced (i.p. 750 μg/kg) compared to the i.p. saline group; #P <0.05,##P< 0.01, LPS-induced (i.c.v. 12 μg) compared to the i.c.v. saline group.
Figure 8. Efect of LPS on Aβ1–42 accumulation in the hippocampus. Immunostaining of Aβ1–42 (green) in thehippocampus was performed with specifc primary antibodies, quantifed images of n =5 per group. Graphis plotted as the mean +SEM. *P <0.05, **P<0.01 LPS (i.p. 500 μg/kg) compared to the i.p. saline group;ΔP <0.05, ΔΔP < 0.01 LPS (i.p. 750 μg/kg) compared to the i.p. saline group; #P <0.05, ##P< 0.01, LPS (i.c.v. 12μg) compared to the i.c.v. saline group
Figure 9. VIPER treatment attenuates cognitive dysfunction and neuroinfammation. (A) Efects of VIPER onLPS-induced memory defcit evaluated by the MWM and passive avoidance performance test. (B,C) VIPERattenuates LPS-induced proinfammatory cytokines and protein accumulation. (n = 10). *P <0.05, **P <0.01LPS-induced (i.p. 750 μg/kg) compared to the i.p. VIPER +LPS group